| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PIII | Class A Common Stock | Purchase | $181,800 | +90,000 | +0.18% | $2.02 | 49,395,442 | 05 Sep 2023 | See Footnote | F1, F2, F3 |
| transaction | PIII | Class A Common Stock | Purchase | $191,520 | +90,000 | +0.18% | $2.13 | 49,485,442 | 06 Sep 2023 | See Footnote | F1, F3, F4 |
| transaction | PIII | Class A Common Stock | Purchase | $185,319 | +90,000 | +0.18% | $2.06 | 49,575,442 | 07 Sep 2023 | See Footnote | F1, F3, F5 |
| Id | Content |
|---|---|
| F1 | Includes (i) 69,433.68 shares of Common Stock directly acquired by CPF III PT SPV, LLC ("SPV III") and (ii) 20,566.32 shares of Common Stock directly acquired by CPF III PT SPV-A, LLC ("SPV-A III"). |
| F2 | The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.975 to $2.07, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 2. |
| F3 | Chicago Pacific Founders UGP, III LLC ("UGP III") is the general partner of Chicago Founders GP III, LP ("GP III"), the general partner of each of SPV III and SPV III-A. As a result, UGP III has the power to vote and dispose of the Issuer's securities held by SPV III and SPV III-A (the "Underlying Securities"). Each of UGP III and GP III disclaims beneficial ownership for the amount in excess of their pecuniary interest in the Underlying Securities. |
| F4 | The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.045 to $2.19, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 4. |
| F5 | The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.025 to $2.10, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 5. |
This amended Form 4 is filed to correct the total number of shares of Class A Common Stock owned by the reporting persons due to a reporting error which first occurred in the Form 4 filed by the reporting persons on August 30, 2023.